Topical Use of 2% Tofacitinib for Nail Psoriasis: an Exploratory Clinical Study
NCT07313072
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Nail Psoriasis
Interventions
DRUG:
Topical 2% Tofacitinib
Sponsor
Hexsel Dermatology Clinic